Intranasal Delivery of Bromocriptine loaded Lipid Nano Carriers for Enhanced Brain Delivery in Parkinson’s disease
Objective: The objective of this research work is to develop a lipid nanocarrier system of Bromocriptine and evaluate its increased efficacy in the management of…Genetic defects causing complex movement disorders and basal ganglia degeneration in childhood
Objective: To characterize genotype–phenotype correlations in basal ganglia degeneration (BGD) in childhood. Background: BGD in childhood causes movement disorders, neurodevelopmental dysfunction and long-lasting severe disability.…Expanding the clinical phenotype of BPAN: A case report
Objective: To describe an atypical presentation of a rare NBIA disorder Background: Beta-propeller protein-associated neurodegeneration (BPAN) manifests in infancy as an initially static encephalopathy with…An international survey of stiff person spectrum disorders: Exploring the clinical spectrum and unmet needs
Objective: To build a platform in order to investigate the clinical spectrum of stiff person syndrome and related disorders, and to explore possible gaps in…Thalamic deep brain stimulation of the ventral intermediate nucleus in patients with dystonic head tremor
Objective: We aimed to evaluate the clinical benefit of Vim DBS in patients with dystonic head tremor. Background: Deep brain stimulation (DBS) of the internal…Post-Deep Brain Stimulation Psychosis in Parkinson’s Disease: A Meta-analysis
Objective: This systematic review and meta-analysis was designed to evaluate risk factors and correlates of psychosis in PD after DBS surgery. Background: Deep brain stimulation…Distance to white matter tracts predicts STN deep brain stimulation outcome of tremor and dysarthria in Parkinson’s disease
Objective: To establish the association between the distance of subthalamic nucleus (STN) deep brain stimulation (DBS) electrode contact points to relevant white matter tracts and…Poor responders to STN DBS in Parkinson’s disease: 1 year follow-up study
Objective: To determine which factors contribute to a poor outcome at 1 year after Deep Brain Stimulation (DBS) of the Subthalamic Nucleus (STN). Background: The…Could the rate of dopaminergic medications reduction affect outcome after STN-DBS?
Objective: A retrospective analysis of the rate of dopaminergic drugs reduction following subthalamic nucleus Deep Brain Stimulation (STN-DBS) in a group of Parkinson’s disease patients…Symptom specified target and procedure selection for Parkinson’s disease: A case report
Objective: To examine the clinical benefits and side effects of combined stereotactic surgery, namely ventralis intermedius (VIM) thalamotomy and bilateral asymmetric GPi/STN DBS, for Parkinson's…
- « Previous Page
- 1
- …
- 167
- 168
- 169
- 170
- 171
- …
- 177
- Next Page »